HopeStage
Back to all studies
RecruitingNCT05671185

Comparing rTMS approaches for depressive symptoms in schizophrenia

About this titleRead the official source — NCT05671185
Device studyAges 20+Taiwan
The study in practice

Understand this study

Who could participate?

Listed age limits: from 20 years.

Listed locations
Douliu, YunlinSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
180
Sponsor
National Taiwan University Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
Taiwan
Age range
Over 20 Years
Official registry ID
NCT05671185
Official title
Show the full official title

Therapeutic Effect of Repetitive Transcranial Magnetic Stimulation for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients

Recruitment & locations

Currently recruiting

Douliu, Yunlin

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Taiwan University Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: from 20 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies